Management of peyronie's disease - A review

World Journal of Urology

Volumn 19, Issue 4, 2001, Pages 244-250

  Gurunadha Rao Tunuguntla, Hari Siva ^a,b  

^a North Florida Urology Research Institute ^*  (United States)

^b North Florida Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOLOGY; HUMAN; IMPOTENCE; MALE; PATHOPHYSIOLOGY; PENIS; PENIS ERECTION; PEYRONIE DISEASE; PHYSIOLOGY; REVIEW; RISK FACTOR;

HUMANS; IMPOTENCE; MALE; PENILE ERECTION; PENILE INDURATION; PENIS; RISK FACTORS;

EID: 0035434289     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450100209     Document Type: Article

References (48)

1. Amin Z, Patel U, Friedman EP, et al (1993) Color Doppier and duplex ultrasound assessment of Peyronie's disease in impotent men. Br J Radiol 66: 398-4402
2. Bivalacqua TJ, Diner EK, Novak TE, et al (2000) A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29-May 4, Atlanta, Georgia. 745
3. Bour H (1984) Current status of vitamin E. Rev Prat 34: 1270-1271
4. Brannigan RE, Kim ED, Oyasu R, et al (1998) Comparison of tunica albuginea substitutes for the treatment of Peyronie's disease. J Urol 159: 1064-1068
5. Chesney J (1975) Peyronie's disease. Br J Urol 47: 209-218
6. Carson CC (1997) Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective? Tech Urol 3: 135-139
7. Chiang PH, Chiang CP, Shen MR, et al (1992) Study of the changes in collagen of the tunica albuginea in venogenic impotence and Peyronie's disease. Eur Urol 21: 48-51
8. El-Sakka AI. Lue TF (1998) Peyronie's disease. Curr Opin Urol 8: 203-209
9. El-Sakka AI, Rashwan HM, Lue TF (1998) Venous patch graft for Peyronie's disease. Part II: Outcome analysis. J Urol 160: 2050-2053
10. Elterman L, Bewsey K, Cs-Szabo G, et al (2000) Connective tissue components of Peyronie's disease plaque. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29-May 4, Atlanta, Georgia. 748
11. Fitkin J, Ho GT (1999) Peyronie's disease: current management. Am Fam Physician 60: 549-552)
12. Furlow WL, Swanson HE, Lee RE (1975) Peyronie's disease: A study of its natural history and treatment with orthovoltage radiotherapy. J Urol 114: 69-71
13. Gelbard MK, Hayden B (1991) Expanding contractures of the tunica albuginea due to Peyronie's disease with temporalis fascia free grafts. J Urol 145: 772
14. Gelbard MK, Dorey F, James K (1990) The natural history of Peyronie's disease. J Urol 144: 1376-1379
15. Hauck W, Warten U, Hackstein H, et al (2000) HLA-system screening in Peyronie's disease. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29-May 4, Atlanta, Georgia. 744
16. Hauck EW, Altinkilic BM, Ludwig M, et al (2000) Extracorporal shock wave therapy in the treatment of Peyronie's disease. Eur Urol 38: 663-670
17. Hellstrom WJ, Bivalacqua TJ (2000) Peyronie's disease: etiology, medical, and surgical therapy. J Androl 21: 347-354
18. Henry GD, Coming TJ, Makuli, MJ, et al (2000) Histochemical analysis of vein grafting of the tunica albuginea in comparison to tunica vaginalis. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29 - May 4, Atlanta, Georgia. 749
19. Husain J, Lynn NNK, Jones DK (2000) Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience. BJU Int 86: 466-468
20. Jarow JP, Löwe FC (1997) Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction. J Urol 157: 13881390
21. Jean VO, Wessells H, Jordan JH, et al (2000) Partial penile disassembly and corporeal resection Peyronie's disease with distal narrowing. J Urol 164: 449-450
22. Kadioglu A, Tefekli A, Erol H, et al (2000) Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease. Int J Impotence Res 12(): 263-268
23. Levine LA, Goldman KE (2000) Updated experience with intralesional verapamil injection treatment for Peyronie's disease. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29 May 4, Atlanta, Georgia. 751
24. Levine LA, Lenting EL (1997) A surgical algorithm for the treatment of Peyronie's disease. J Urol 158: 2149-2152
25. Lopez JA, Jarrow JP (1993) Penile vascular evaluation of men with Peyronie's disease. J Urol 149: 53-55
26. Ludwig G (1991) Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis). Urol Int 47: 236-239
27. Lue TF (1998) 1998 AUA Annual Meeting (San Diego '98) PG course, "Erectile dysfunction, priapism and Peyronie's disease": Functional anatomy of the penis. AUA Office of Education, Course No 009821 PG; Sunday, May 31, 1998
28. Lue TF, El-Sakka AI (1998) Venous patch graft for Peyronie's disease. Part I: technique. J Urol 160: 2047-2049
29. Matkov G, Levine LA, Storm DW (2000) Peyronie's disease affecting the younger male. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29 May 4, Atlanta, Georgia. 743
30. Michel MS, Braun P, Sazova O, et al (1999) Shock wave therapy for the treatment of Peyronie's disease: first clinical study for the objective determination of deviation improvement by means of artificial erection. J Urol 161: 262
31. Mirone V, Imbimbo C. Palmieri A, et al (1999) Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Eur Urol 36: 327-330
32. Montague DK, Angermeier KW, Lakin MM, et al (1996) AM S 3-piece inflatable penile implantation in men with Peyronie's disease: comparison of CX and Ultrex cylinders. J Urol 156: 1633-1635
33. Montorsi F, Salonia A, Maga T, et al (2000) Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. J Urol 163: 1704-1708
34. Mulhall JP, Lubrano T, Thorn J, et al (2000) Cytogenetic evidence in support of Peyronie's disease being a tunical field defect process. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29 - May 4, Atlanta, Georgia. 747
35. Muralidhar S, Gulati M, Kumar B, et al (1996) An ultrasonographic study of Peyronie's disease. Australas Radiol 40: 106-108
36. Poutasse EF (1972) Peyronie's disease. J Urol 107: 419-422
37. Ralph DJ (1999) What's new in Peyronie's disease? Curr Opin Urol 9(): 569-571
38. Ralph DJ, Hughes T, Lees WR, et al (1992) Pre-operative assessment of Peyronie's disease using colour Doppler sonography. Br J Urol 69: 629-632
39. Riedl CR, Plas E, Engelhardt P, et al (2000) Iontophoresis for treatment of Peyronie's disease. J Urol 163: 95
40. Roberts HJ (1995) Vitamin E. Lancet 345: 737
41. Schwarzer U, Klotz T, Braun M, et al (2000) Prevalence of Peyronie's disease: results of an 8,000 men survey. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29 - May 4, Atlanta, Georgia. 742
42. Somers KD, Sismour EN, Wright GL, et al (1989) Isolation and characterization of collagen in Peyronie's disease. J Urol 141: 629-631
43. Stojic M, Negrojevic M, Josic P, et al (1987) Conservative therapy of Peyronie's disease using vitamin E. Med Pregl 40: 133-135
44. Teloken C, Rhoden EL, Grazziotin TM, et al (1999) Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 162: 2003-2005
45. van der Drift DGF, Vroege JA, Groenendijik PM, et al (2000) The plication procedure for penile curvature: surgical outcome and post-operative sexual function. Program and abstracts from the American Urological Association 95th Annual Meeting; April 29 - May 4, Atlanta, Georgia. 753
46. Wayne JG, Hellstrom WJ, Reddy S (2000) Application of pericardia! graft in the surgical management of Peyronie's disease. J Urol 163: 1445-1447
47. Weidner W, Schroeder-Printzen I, Weiske WH (1997) Sexual dysfunction in Peyronie's disease: an analysis of 222 patients without previous local plaque therapy. J Urol 157: 325-328
48. Weidner W, Schroeder-Printzen I, Rudnick J, et al (1999) Randomized prospective placebo-controlled therapy of Peyronie's disease (IPP) with Potaba (aminobenzoate potassium). J Urol 161[Suppl]: 205